Search

Your search keyword '"Furrer, Hj"' showing total 32 results

Search Constraints

Start Over You searched for: Author "Furrer, Hj" Remove constraint Author: "Furrer, Hj"
32 results on '"Furrer, Hj"'

Search Results

1. Why do sub‐Saharan Africans present late for HIV care in Switzerland?

2. Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial

3. Combination antiretroviral therapy and duration of pregnancy

4. High prevalence of the metabolic syndrome in HIV-infected patients: impact of different definitions of the metabolic syndrome

5. HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignancies

6. Changes over time in risk factors for cardiovascular disease and use of lipid-lowering drugs in HIV-infected individuals and impact on myocardial infarction

7. Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration

8. Human immunodeficiency virus-specific T lymphocyte cell

11. A Longitudinal Analysis of Healthcare Costs after Treatment Optimization following Genotypic Antiretroviral Resistance Testing: Does Resistance Testing pay off?

12. Long-Term Virological Response to Multiple Sequential Regimens of Highly Active Antiretroviral Therapy for HIV Infection

13. Effect of Individual Cognitive Behaviour Intervention on Adherence to Antiretroviral Therapy: Prospective Randomized Trial

14. Impact of Genotypic Resistance Testing on Selection of Salvage Regimen in Clinical Practice

15. Drug Resistance Mutations in HIV-1-Infected Subjects during Protease Inhibitor-Containing Highly Active Antiretroviral Therapy with Nelfinavir or Indinavir

16. Coping with an HIV infection. A multicenter qualitative survey on HIV positive adolescents' perceptions of their disease, therapeutic adherence and treatment

17. Predictors of trend in CD4-positive T-cell count and mortality among HIV-1 infected individuals with virological failure to all three antiretroviral-drug classes

18. The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era.

19. Hepatitis A vaccines and the elderly.

20. [The genetics HIV cohort of the Swiss HIV Cohort Study--facing the new challenges in medicine].

21. [Opportunistic diseases in HIV infection].

22. [Respiratory tract viruses].

23. [Antiviral therapy and resistance formation exemplified by HIV infection].

24. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population.

25. Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study.

26. Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study.

27. [Epidemiology of HIV-1 infection in Bern--application of molecular methods].

28. [Prevention of malignant skin tumors].

29. A controlled study of inhaled pentamidine for primary prevention of Pneumocystis carinii pneumonia.

30. Primary prevention of Pneumocystis carinii pneumonia by inhalation of pentamidine. Preliminary results from a placebo-controlled randomized trial. Swiss Group for Clinical Studies on AIDS.

31. Efficacy and tolerance of a miconazole-benzoyl peroxide cream combination versus a benzoyl peroxide gel in the topical treatment of acne vulgaris.

32. [Exogenous light protection].

Catalog

Books, media, physical & digital resources